Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.
Schindler EAD, Sewell RA, Gottschalk CH, Flynn LT, Zhu Y, Pittman BP, Cozzi NV, D'Souza DC
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (5)
- Clinical Evidence on Psilocybin and Its Representation in Media Reporting 2026-10-20 · Expand citations
- Psychedelics in neurosurgery: Potential utility in prevention, perioperative care, pain management, and neurorehabilitation 2026-10-09 · Expand citations
- Pilot study of psilocybin in patients with post-treatment lyme disease 2026-02-25 · Expand citations
- Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications 2025-10-31 · Expand citations
- Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series 2025-05-01 · Expand citations